Anzeige
Mehr »
Login
Montag, 20.05.2024 Börsentäglich über 12.000 News von 688 internationalen Medien
GOLD-MINEN vor Jahrhundert-Hausse?! Diese Aktie sofort kaufen!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Übersicht Suchergebnisse zum Thema OCEAN BIOMEDICAL INC.

ZeitNachrichten
Sprache: Alle DE EN
LeserMedien
DoOcean Biomedical, Inc. Announces Patent Allowance for Malaria Antibodies That Have Potential Capability to Protect Against Infection and Treat Severe Disease-
DiOcean Biomedical, Inc. - NT 10-Q, Notification of inability to timely file Form 10-Q or 10-QSB1
24.04.Ocean Biomedical, Inc. - 8-K, Current Report4
24.04.Ocean Biomedical, Inc. Announces Receipt of Notice from Nasdaq Regarding Late Filing of Annual Report on Form 10-K453PROVIDENCE, Rhode Island, April 24, 2024 (GLOBE NEWSWIRE) -- Ocean Biomedical, Inc. (NASDAQ: OCEA), today announced that on April 18, 2024, it received a notice from The Nasdaq Stock Market LLC ("Nasdaq")...
► Artikel lesen
16.04.Ocean Biomedical Inc reports results for the quarter ended in September - Earnings Summary3
15.04.Ocean Biomedical, Inc. - 10-Q, Quarterly Report3
15.04.Ocean Biomedical, Inc. - 10-Q/A, Quarterly Report1
01.04.Ocean Biomedical, Inc. - NT 10-K, Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT4055
28.03.Ocean Biomedical, Inc.: Ocean Biomedical Congratulates JV Partner, Virion Therapeutics, on Promising First-Ever Human Phase 1B Clinical Safety Data for Their Lead Checkpoint Modifier-Containing Immunotherapy for HBV Functional Cure, at Global APASL106Providence, RI, March 28, 2024 (GLOBE NEWSWIRE) -- Ocean Biomedical, Inc. (NASDAQ: OCEA), a biopharma company working to accelerate the development of compelling discoveries from top research scientists...
► Artikel lesen
25.03.Ocean Biomedical Inc expected to post a loss of 15 cents a share - Earnings Preview3
18.03.Ocean Biomedical Inc expected to post a loss of 15 cents a share - Earnings Preview2
08.03.Ocean Biomedical, Inc. - 8-K, Current Report7
08.03.Ocean Biomedical Inc expected to post a loss of 15 cents a share - Earnings Preview4
29.02.Ocean Biomedical, Inc.: Ocean Biomedical Announces Joint Venture Partner, Virion Therapeutics to Present Their First Clinical Study Data as an Accepted Late Breaker Presentation at 2024 APASL Global Liver Meeting27
20.02.Ocean Biomedical Inc expected to post a loss of 15 cents a share - Earnings Preview25
12.02.Ocean Biomedical Inc expected to post a loss of 15 cents a share - Earnings Preview4
17.01.Ocean Biomedical, Inc. - 8-K, Current Report5
12.01.Ocean Biomedical Inc expected to post a loss of 15 cents a share - Earnings Preview1
08.12.23Ocean Biomedical Inc expected to post a loss of 15 cents a share - Earnings Preview4
05.12.23Ocean Biomedical, Inc. Announces Publication of Groundbreaking Breast Cancer Research Uncovering a New Tumor Suppression Pathway for Its Proprietary Anti-Chi3L1 Antibody287Results published in the Journal Immunity share discovery of a new mechanism by which Chi3L1 regulates breast cancer development and progression PROVIDENCE, Rhode Island, Dec. 05, 2023 (GLOBE NEWSWIRE)...
► Artikel lesen
Seite:  Weiter >>